Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
Alkem Laboratories shares are in focus after promoter-linked entities sold 1.49% via a Rs 930 crore block deal at Rs 5,200, with mutual funds and global banks buying.
Concord Biotech received USFDA approval for its ANDA for Mycophenolate Mofetil oral suspension, with the stock up 10% and Jefferies maintaining a Hold rating.
Bliss GVS Pharma extended a sharp multi-session rally after Anupam Rasayan announced a 43.3% acquisition and open offer, with profits up 128.96% year-on-year.
NHPC shares fell as the Government of India launched a 3% OFS with a 3% green shoe at a ₹71 floor price, about 8% below the prior close.
Rajputana Stainless reported a 58% YoY jump in Q4FY26 profit to ₹13.1 crore, aided by a 191 bps margin expansion and FY26 revenue crossing ₹1,000 crore.
Foreign investors have accelerated secondary-market selling in 2026 to over ₹400 crore per trading hour, with year-to-date outflows already exceeding the full-year 2025 total.
ICRA reported FY26 consolidated revenue of ₹599.5 crore and PBT of ₹257.4 crore, while recommending a ₹105 final dividend as Research and Analytics outpaced Ratings.
Sreeleathers posted FY26 net profit growth of 27.3% on higher sales, announced a Re 1 final dividend, and added an independent director after audited results.
Pondy Oxides posted record FY26 numbers with revenue up 45% to ₹2,939 crore and PAT up 113% to ₹139 crore, alongside major capacity expansion plans.
India Glycols reported FY26 net revenue of ₹4,211 crore with EBITDA up 24.5% to ₹654 crore and PAT up 26.8% to about ₹293 crore, alongside lower leverage.
Saksoft reported FY26 revenue of INR 1,007 crore with EBITDA margin expansion to 18.57%, while flagging slower customer decision cycles and AI-linked pricing pressure risks.
RedTape posted Q4FY26 revenue from operations of ₹675.51 crore and PAT of ₹69.88 crore, alongside margin improvement and a recommended final dividend of ₹2 per share.
Arham Technologies reported sharp FY26 growth in revenue and profit, and reiterated its ₹300 crore FY28 guidance backed by expansion, capex, and higher brand spending.
Brokerages largely reiterate Buy on Adani Ports, with updated targets ranging from ₹1,710 to ₹2,178 even as the stock slipped about 1.1% in late May 2026.
Paras Defence and Space Technologies traded higher on June 2, 2026, with a wide intraday range, mixed index cues, and user sentiment showing 100% buy recommendations on Moneycontrol.
Lords Chloro Alkali reported FY26 total income of ₹393.10 crore and PAT of ₹28.49 crore, with Q4 gains supported by higher volumes and margin expansion.